If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMULIN® R U-500 (insulin human injection): Route of Administration
Humulin R U-500 should be injected subcutaneously into the thigh, upper arm, abdomen, or buttocks.
Patients should inject their prescribed dose of U-500R SC into the
Injection sites should be rotated within the same region from one injection to the next to reduce the risk of lipodystrophy. Do not administer U-500R IV or IM.
Enclosed Prescribing Information
CSII = continuous subcutaneous insulin infusion
IM = intramuscular
IV = intravenous
SC = subcutaneous
U-500R = Humulin® R U-500 (insulin human injection) 500 units/mL
Date of Last Review: June 06, 2019